Y Ogawa, Y Kawakami, K Tsubota - International journal of molecular …, 2021 - mdpi.com
Ocular graft-versus-host disease (GVHD) is a major complication after allogeneic hematopoietic stem cell transplantation. Ocular GVHD affects recipients' visual function and …
M Calonge, I Pérez, S Galindo, T Nieto-Miguel… - Translational …, 2019 - Elsevier
Ocular stem cell transplantation derived from either autologous or allogeneic donor corneoscleral junction is a functional cell therapy to manage extensive and/or severe limbal …
Purpose To evaluate the therapeutic effect of subconjunctival injection of human mesenchymal stromal cells (hMSCs) in the cornea of mice with graft versus host disease …
H Nosrati, Z Alizadeh, A Nosrati, K Ashrafi-Dehkordi… - Tissue and Cell, 2021 - Elsevier
Any significant loss of vision or blindness caused by corneal damages is referred to as corneal blindness. Corneal blindness is the fourth most common cause of blindness …
AJ Villatoro, V Fernández, S Claros… - International Journal of …, 2017 - mdpi.com
Dry eye syndrome is a complex and insidious pathology with a high level of prevalence among the human population and with a consequently high impact on quality of life and …
JM Kezic, S Wiffen, M Degli-Esposti - Clinical and Experimental …, 2022 - Taylor & Francis
Ocular graft versus host disease (GVHD) is a common manifestation in patients undergoing allogeneic haematopoietic stem cell transplantation (allo-HSCT). Ocular GVHD affects …
YJ Yang, XL Li, Y Xue, CX Zhang… - Eur Rev Med …, 2016 - europeanreview.org
Bone marrow cells (BMC) are progenitors of bone, cartilage, skeletal tissue, the hematopoiesis-supporting stroma and adipocyte cells. BMCs have the potential to …
Graft-versus-host disease is among the most common clinical complications following allogeneic hematopoietic stem cell transplantation. It causes inflammation-mediated …
RML Vitar, F Bonelli, A Atay, F Triani, P Fonteyne… - Experimental Eye …, 2021 - Elsevier
Purpose to assess the effect of topical administration of the Neurokin-1 receptor (NK1R) antagonist Fosaprepitant in a pre-clinical model of ocular Graft-versus-Host disease …